^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs)

    i
    Company:
    Halozyme, Roche
    Drug class:
    PD-L1 inhibitor
    Related drugs: